- Global Pharma News & Resources

Middle East and Africa Artificial Blood Substitutes Market 2021: Industry Review, Research, Statistics, and Growth to 2028

Market Analysis and Insights : Middle East and Africa Artificial Blood Substitutes Market

The artificial blood substitutes market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 23.7% in the forecast period of 2021 to 2028 and is expected to reach USD 1,966.01 thousand by 2028. Limited availability of fresh blood and its short life span coupled with increasing demand for blood transfusion and increased funding for development of blood substitutes acts as driver for the artificial blood substitutes market growth.

Artificial blood substitutes are also known as oxygen therapeutics or haemoglobin-based oxygen carriers. It is used to mimic the function of biological blood and to offer a substitute to blood transfusion. Artificial blood are used as a solution to replace transfusion of banked red blood cells and are designed to overcome the limitations such as shortage of blood sonor, high risk contamination, requirement of cross matching. The allogenic blood transfusions has multiple risks and can cause infectious transmission, transfusion reactions, transfusion related acute lung injury, delayed postoperative wound healing, immunomodulation and potential risk of cancer recurrence. It offers the promise of new and important life-saving medical treatments.

Download Exclusive Sample of this Premium Report With Charts and Graphs @

Leading Companies Operating at both regional and global levels:

Competitive Landscape and Artificial blood substitutes Market Share Analysis

The major companies which are dealing in the artificial blood substitutes are  HEMARINA, Hemoglobin Oxygen Therapeutics LLC, KaloCyte, Inc., LLC “Visusmed”, European Medicines Agency, OPK Biotech LLC, NuvOx Pharma, Prolong Pharmaceuticals, LLC, Boston Therapeutics, Inc., Aurum Biosciences, OXYVITA Inc, NanoBlood LLC among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many expansion and funding are also initiated by the companies’ worldwide which are also accelerating the artificial blood substitutes market.

For instance,

  • In November 2020, Hemarina published a scientific report for anti-inflammatory and antibacterial property of M 101, an oxygen transporter for the treatment of periodontitis. This study has validated the quality of M 101 molecolue, which is derived from haemoglobin of the marine lugworm.
  • In June 2020, KaloCyte, Inc. received a USD 300k funding from University System of Maryland (USM) Momentum Fund for developing ErythroMer, a synthetic, bio-inspired red blood substitute. This funding has helped the company in developing the ErythroMer at much faster pace.
  • In May 2020, KaloCyte, Inc. awarded by the National Institutes of Health (NIH) a USD 373,000 Small Buisness Innovation Resaerch (SBIR) Phase I grant. This grant helped the company in advancing KaloCyte product to preclinical safety and efficacy testing in anticipation of human trails.

Global Thrombophilia Market Scope and Market Size

Thrombophilia market is segmented on the basis of type, drug, route of administration, end-users and distribution channel.

  • On the basis of type, the market is segmented into factor V Leiden, prothrombin 20210, antiphospholipid syndrome and others
  • Based on drug, the market is segmented into heparin, warfarin and others
  • The route of administration segment for global thrombophilia market is segmented into oral and injections
  • On the basis of end-users, the market is segmented into hospitals, homecare, speciality centres and others
  • On the basis of distribution channel, the market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy

Get Full TOC Of This Report @

Global Neurosurgery Market: Regional Analysis

North America [U.S., Canada, Mexico]

Europe [Germany, UK, France, Italy, Rest of Europe]

Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]

South America [Brazil, Argentina, Rest of Latin America]

Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

Highlights Points of the Market:

  • The latest information on how the market is evolving to formulate their sales and marketing strategies. This Arginase Deficiency Market report has been created to provide its readers with up-to-date information and analysis to uncover emerging opportunities for growth.
  • The market report covers the key challenges, competitive landscape, and demographic analysis that can help companies get insight into the country-specific variations.
  • The analysts also emphasize on the key trends and the future opportunities that can be explored in the region than can help companies in revenue expansion.
  • To gain competitive intelligence about leading companies with information about their market share and growth rates.

Know More About This Premium Research Report @

Advantages of the Study

-To depict and estimate the at-home testing packs market, as far as worth, by measure, item type, and industry.

-To deliberately profile vital participants and completely break down their market position regarding positioning and center abilities, and detail the serious scene for market pioneers

-Item Development/Innovation: Detailed bits of knowledge on the item endorsements, R&D exercises, and item dispatches in the at-home testing units market

-Methodologies of central participants and item contributions

-Top to bottom market division

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe, or Asia Etc.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is adept at creating satisfied clients who reckon upon our services and rely on our hard work with certitude.

We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email –

Editor Details

  • Company:
    • The Wire Times
Last Updated: 10-Dec-2021